Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Adastra Pharmaceuticals
AddedFeb 15, 2024
UpdatedJun 18, 2026
Adastra Pharmaceuticals

Adastra Pharmaceuticals

Acquired

Adastra: A private pharmaceutical firm specializing in the development of proprietary cancer treatments.

HQ
San Diego, CA, US
Founded
2005
Overview
Compare
Fundraising
Employees
Website

Adastra Pharmaceuticals, founded in San Diego, California, and Princeton, New Jersey, is a privately held company dedicated to the clinical and commercial development of proprietary medicines for cancer treatment. The company's core mission is to innovate and provide effective treatments for the most aggressive forms of cancer, with a strong emphasis on research and development. Adastra's market focus is on high-grade gliomas and other challenging cancer types.

Notable affiliated people include key researchers and industry veterans who drive the company's mission forward. Adastra has achieved significant milestones, including the development and subsequent acquisition of their drug zotiraciclib (ZTR) by Cothera Bioscience. This acquisition underscores Adastra's impact on advancing cancer treatment options and their commitment to improving patient outcomes.

Adastra Pharmaceuticals - Similar Companies

Adhera Therapeutics logo

Adhera Therapeutics

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Adventris Pharmaceuticals logo

Adventris Pharmaceuticals

Novita Pharmaceuticals logo

Novita Pharmaceuticals

novita-pharm.com

Whitehawk Therapeutics logo

Whitehawk Therapeutics

aadibio.com

Panacea Pharmaceuticals logo

Panacea Pharmaceuticals

Advanced Cancer Therapeutics logo

Advanced Cancer Therapeutics

Altiris Therapeutics logo

Altiris Therapeutics

Acadia Pharmaceuticals logo

Acadia Pharmaceuticals

acadia-pharm.com

Camino Pharma logo

Camino Pharma

caminopharma.com

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Ascenta Therapeutics logo

Ascenta Therapeutics

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

EtiraRx logo

EtiraRx

etirarx.com

Thetis Pharmaceuticals logo

Thetis Pharmaceuticals

thetispharma.com

Adastra Pharmaceuticals - Quick Facts

Who are Adastra Pharmaceuticals' competitors?

Companies similar to Adastra Pharmaceuticals include Adhera Therapeutics, Tigris Pharmaceuticals, Adventris Pharmaceuticals and Novita Pharmaceuticals.

When was Adastra Pharmaceuticals founded?

Adastra Pharmaceuticals was founded in 2005.

Where is Adastra Pharmaceuticals' headquarters located?

Adastra Pharmaceuticals' headquarters is located in San Diego, CA, US.

When was Adastra Pharmaceuticals' last funding round?

Adastra Pharmaceuticals' most recent funding round was for $3.3M (USD) in November 2016.

How much has Adastra Pharmaceuticals raised to-date?

As of Nov 15, 2016, Adastra Pharmaceuticals has raised a total of $85M (USD).

Adastra Pharmaceuticals - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatments
Tags
  • Financial
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified